DFMG decreases angiogenesis to uphold plaque stability by inhibiting the TLR4/VEGF pathway in mice
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0302387 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Pingjuan Bai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi Province, China. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, MicroRNAs. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
The aim of this study was to elucidate the specific mechanism through which 7-difluoromethoxy-5,4’-dimethoxygenistein (DFMG) inhibits angiogenesis in atherosclerosis (AS) plaques, given its previously observed but poorly understood inhibitory effects. In vitro, a model using Human Umbilical Vein Endothelial (HUVEC-12) cells simulated the initial lesion in the atherosclerotic pathological process, specifically oxidative stress injury, by exposing cells to 30 μmol/L LPC. Additionally, an AS mouse model was developed in ApoE knockout mice through a 16-week period of high-fat feeding. DFMG demonstrated a reduction in tubule quantities in the tube formation assay and neovascularization induced by oxidative stress-damaged endothelial cells in the chicken embryo chorioallantoic membrane assay. Furthermore, DFMG decreased lipid levels in the blood of ApoE knockout mice with AS, along with a decrease in atherosclerotic plaques and neovascularizations in the aortic arch and descending aorta of AS animal models. DFMG treatment upregulated microRNA140 (miR-140) expression and suppressed VEGF secretion in HUVEC-12 cells. These effects were counteracted by Toll-like receptor 4 (TLR4) overexpression in HUVEC-12 cells subjected to oxidative injury or in a mouse model of AS. Dual-luciferase reporter assays demonstrated that miR-140 directly targeted TLR4. Immunohistochemical assay findings indicated a significant inverse relationship between miR-140 expression and TLR4 expression in ApoE knockout mice subjected to a high-fat diet. The study observed a close association between DFMG inhibitory effects on angiogenesis and plaque stability in AS, and the inhibition of the TLR4/NF-κB/VEGF signaling pathway, negatively regulated by miR-140.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Pathology Department, Jiangxi Maternal and Child Health Hospital, Nanchang, Jiangxi Province, China.
- Medical College of Hunan Normal University, Changsha, Hunan Province, China.
- Hunan Cancer Hospital, Changsha, Hunan Province, China.
ORCID-Profile: Pingjuan Bai
Förderung
- Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Bai, P., Xiang, X., Kang, J., Xiang, X., Jiang, J., Fu, X., Zhang, Y., & Li, L. (2024). DFMG decreases angiogenesis to uphold plaque stability by inhibiting the TLR4/VEGF pathway in mice. PLOS ONE. https://doi.org/10.1371/journal.pone.0302387
Vancouver
Bai P, Xiang X, Kang J, Xiang X, Jiang J, Fu X, et al. DFMG decreases angiogenesis to uphold plaque stability by inhibiting the TLR4/VEGF pathway in mice. PLOS ONE. 2024. doi:10.1371/journal.pone.0302387
BibTeX
@article{Bai2024,
author = {Bai, Pingjuan and Xiang, Xueping and Kang, Jiawen and Xiang, Xiaoqing and Jiang, Jingwen and Fu, Xiaohua and Zhang, Yong and Li, Lesai},
title = {DFMG decreases angiogenesis to uphold plaque stability by inhibiting the TLR4/VEGF pathway in mice},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0302387}
}
EUVIMED